Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme
Publication
, Conference
Hawkins, NM; Wang, DL; Pocock, SJ; McMurray, JJV; Pfeffer, MA; Swedberg, K; Granger, CB; Yusuf, S; Dunn, FG
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2005
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
2005
Volume
45
Issue
3
Start / End Page
146A / 146A
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hawkins, N. M., Wang, D. L., Pocock, S. J., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., … Dunn, F. G. (2005). Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 45, pp. 146A-146A).
Hawkins, N. M., D. L. Wang, S. J. Pocock, J. J. V. McMurray, M. A. Pfeffer, K. Swedberg, C. B. Granger, S. Yusuf, and F. G. Dunn. “Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45:146A-146A, 2005.
Hawkins NM, Wang DL, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, et al. Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005. p. 146A-146A.
Hawkins, N. M., et al. “Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 45, no. 3, 2005, pp. 146A-146A.
Hawkins NM, Wang DL, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Dunn FG. Electrocardiographic left ventricular hypertrophy is associated with worse clinical outcomes in heart failure: Evidence from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2005. p. 146A-146A.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
2005
Volume
45
Issue
3
Start / End Page
146A / 146A
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology